Notch increases T/NK potential of human hematopoietic progenitors and inhibits B cell differentiation at a pro-B stage.
Notch and its ligands regulate multiple cell fate decisions. However, several questions on the timing, durability, and reversibility of Notch signaling effects on human hematopoietic precursors are still unresolved. Here, we used recombinant Delta ligands to deliver temporally and dose-controlled signals to human immature cord blood CD34(+)CD38(low) cells at clonal cell levels. Notch activation increased the frequency of multipotent progenitors, skewed the T and natural killer (NK) cell potential of CD34(+)CD38(low) clones in a dose- and ligand-dependent manner, and inhibited the differentiation of B cell clones. Low doses of ligands were sufficient for significantly increasing the frequency of NK cell precursors, whereas higher doses were required for increasing the frequency of T-cell clones. Interestingly, we demonstrate that temporary Notch activation prevents the subsequent differentiation of CD34(+)CD38(low) cells beyond a pro-B CD79a(+)CD19(-) stage characterized as a common lymphoid progenitor (CLP). Moreover, the lymphoid potential of this pro-B/CLP was skewed toward NK cell potential while the B cell precursor frequency was dramatically reduced. These results indicate critical timing and quantitative aspects of Notch/Delta interactions, imprinting the potential of CD34(+)CD38(low) hematopoietic progenitors. These results may have implications both in physiology and for cell manipulation because they demonstrate a tight regulation of the fate of human progenitors by Notch signaling.
Benne
Clarisse
C
INSERM, Unité U955, Créteil, France.
Lelievre
Jean Daniel
JD
Balbo
Michelle
M
Henry
Adeline
A
Sakano
Seiji
S
Levy
Yves
Y
D051997:ADP-ribosyl Cyclase 1 / Q000378:metabolism; D000818:Animals; D018952:Antigens, CD34 / Q000276:immunology; D001402:B-Lymphocytes / Q000166:cytology* / Q000378:metabolism; D002453:Cell Cycle / Q000235:genetics / Q000502:physiology; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D002478:Cells, Cultured; D005312:Fetal Blood / Q000166:cytology; D005434:Flow Cytometry; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000378:metabolism*; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D007694:Killer Cells, Natural / Q000166:cytology* / Q000378:metabolism; D008565:Membrane Proteins / Q000494:pharmacology; D051379:Mice; D016133:Polymerase Chain Reaction; D051880:Receptors, Notch / Q000378:metabolism*; D013601:T-Lymphocytes / Q000166:cytology* / Q000378:metabolism
D018952:Antigens, CD34; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins; D051880:Receptors, Notch; C064045:delta protein; D051997:ADP-ribosyl Cyclase 1